Introduction
============

Male and female eutherian mammals achieve equivalent levels of X-linked gene expression by silencing all but one X chromosome in cells of the developing embryo ([@bib1]; [@bib57]). With the exception of imprinted X inactivation in extraembryonic tissue ([@bib31]), the choice of which X chromosome to inactivate in the soma is random and maintained throughout subsequent cell divisions. The inactive X chromosome (Xi)[\*](#fn1){ref-type="fn"} shares features common to other types of heterochromatin, including hypoacetylation of histone tails ([@bib32]; [@bib4]; [@bib6]; [@bib27]), hypermethylation of CpG islands ([@bib43]; [@bib48]), late replication in S phase ([@bib26]; [@bib44]), and a characteristic pattern of histone H3 lysine methylation ([@bib7]; [@bib47]). In addition, several unique features characterize heterochromatin of the Xi. These include the association of a large untranslated RNA, the Xi-specific transcript (XIST) ([@bib11]; [@bib9]), and a nonrandom distribution of variants of the core histone H2A ([@bib15]; [@bib12],[@bib13]).

The macroH2A family of H2A variants was first identified through association with nucleosomes ([@bib45]). The amino-terminal third of the protein is almost identical to histone H2A, with a unique nonhistone carboxy-terminal tail. Two separate genes encode macroH2A1 and macroH2A2, both of which are enriched in Xi chromatin ([@bib15], [@bib16]; [@bib12]). The enrichment of macroH2A at the Xi forms a characteristic structure in the female nucleus, referred to as a macrochromatin body (MCB). In cultured differentiating mouse embryonic stem cells (ES), an MCB appears after counting and choice of which X chromosome to inactivate has occurred ([@bib41]; [@bib50]). Although macroH2A has transcriptional repression activity ([@bib46]), it is not essential for the maintenance of X inactivation. The formation of an MCB is dependent upon localization of XIST RNA, as disruption of XIST results in the loss of the MCB without reactivating the Xi ([@bib18]; [@bib3]). Combined, the available data indicate that macroH2A may represent one of several highly redundant mechanisms of gene silencing employed by the Xi ([@bib43]; [@bib52]; [@bib10]; [@bib24]; [@bib18]).

Prior to the onset of X inactivation in ES cells, a cytoplasmic concentration of macroH2A1 is evident, coincident with the centrosome ([@bib50]). When ES cells are stimulated to differentiate, centrosomal macroH2A disappears. More recently, a centrosome-associated pool of macroH2A1 has been observed in somatic cells as well ([@bib42]), raising questions about the relationship between nuclear and centrosomal macroH2A1. In the present study, in order to address the spatial and temporal relationship of macroH2A1 with the centrosome and the MCB, we have investigated the distribution of macroH2A1 during the maintenance phase of X inactivation throughout the somatic cell cycle.

Results
=======

MacroH2A1 and macroH2A2 associate with centrosomes in male and female somatic cells
-----------------------------------------------------------------------------------

A centrosomal association of macroH2A1 was observed in human somatic cells ([Fig. 1](#fig1){ref-type="fig"} a), as previously observed in mouse ([@bib42]), indicating that the centrosomal macroH2A1 pool is not restricted to undifferentiated ES cells ([@bib41]; [@bib50]). In addition, the association with centrosomes in both XY and XX somatic cells indicates that the association is independent of X inactivation. Using independent antisera specific to either the macroH2A1 or the macroH2A2 protein, we detected both forms of macroH2A at the centrosome ([Fig. 1](#fig1){ref-type="fig"} b).

![**Colocalization of macroH2A with centrosomes in somatic cells.** (a) Colocalization of macroH2A1 (green, FITC) with γ-tubulin (red, TRITC) in 46,XX (T-3352) and 46,XY (hTERT-BJ1) cells. Nuclei are stained with DAPI (blue). The white arrowhead indicates the position of the centrosome, determined by γ-tubulin staining. The merged macroH2A1 and γ-tubulin signals indicate overlapping signals in yellow. The white arrow indicates the location of the MCB (green) in the 46,XX nucleus. (b) Colocalization of macroH2A1 and macroH2A2 with γ-tubulin in 46,XX (hTERT-RPE1) cells by indirect immunofluorescence. Cells grown directly on microscope slides were stained with either anti-macroH2A1 or anti-macroH2A2 (aa 124--180). Metaphase chromosomes are stained with DAPI. The white arrowhead indicates the position of the centrosome, determined by γ-tubulin staining. The merged macroH2A and γ-tubulin signals indicate overlapping signals in yellow.](0112074f1){#fig1}

Both forms of macroH2A could also be detected in sucrose gradient fractions enriched for centrosomes ([Fig. 2](#fig2){ref-type="fig"} a). In addition to a signal of anticipated size for macroH2A1, a second band of smaller size was detected in centrosome preparations ([Fig. 2](#fig2){ref-type="fig"} a, lane 1). The same band cofractionates with full-length macroH2A1 in sucrose gradient fractions of nucleosome preparations ([Fig. 2](#fig2){ref-type="fig"} b). Additional bands of comparable size have been detected with independent anti-macroH2A1 antisera ([@bib17]; [@bib42]). Although a smaller macroH2A2 band is not detected in centrosome preparations ([Fig. 2](#fig2){ref-type="fig"} a, lane 2), a considerably weaker smaller band can be detected in nucleosome fractions with antisera specific to macroH2A2 ([Fig. 2](#fig2){ref-type="fig"} c, lane 2). Smaller bands can also be observed in nucleosome preparations from cell lines expressing epitope-tagged forms of macroH2A1 and macroH2A2 ([Fig. 2](#fig2){ref-type="fig"} d). Although the smaller bands observed for the epitope-tagged forms of macroH2A1 and macroH2A2 do not directly correlate to the size of the smaller bands detected with the macroH2A1 and macroH2A2 primary antisera, this may reflect either a direct effect of the presence of the epitope tag on processing or the relative stability of the endogenous proteins. Whether the smaller bands represent the potential breakdown of macroH2A during various purification protocols, or the direct result of an intracellular biological process is unknown. Further, though less likely in our view because of its reproducibility with three independent antisera, the possibility remains that the smaller bands may be unrelated to macroH2A and simply represent a shared epitope between macroH2A and another protein(s) that coexists with macroH2A in both nucleosomal and centrosomal fractions.

![**Detection of macroH2A1 and macroH2A2 in fractions from nucleosome and centrosome preparations.** (a) Immunoblot analysis of the same fraction of a centrosome preparation from a 46,XX (hTERT-RPE1) cell line detecting the presence of macroH2A1 (lane 1) or macroH2A2 (aa 124--372; lane 2). The panel below shows the relative level of γ-tubulin by immunoblotting in the same fraction. (b) Immunoblot of five consecutive sucrose gradient fractions (lanes 1--5) of a nucleosome preparation from a 46,XX (hTERT-RPE1) cell line, showing the cofractionation of full-length macroH2A1 (top arrowhead) and a smaller signal (bottom arrowhead). The relative concentration of nucleosomes/histones in each fraction is shown in the Coomassie image below. (c) Immunoblot analysis of the same nucleosome-containing fraction of a nucleosome preparation from a 46,XX (hTERT-RPE1) cell line detecting the presence of macroH2A1 (lane 1) or macroH2A2 (aa 124--372; lane 2). The panel below shows an image of the Coomassie stain of the same fraction indicating the positions of the histones. (d) Immunoblot analysis using anti-Myc mAb detecting the presence of macroH2A1-CT--Myc and macroH2A2-CT--Myc in sucrose gradient fractions of nucleosome preparations from macroH2A1-CT--Myc- and macroH2A2-CT--Myc-expressing HEK-293 cell lines. The arrowheads to the right of each image indicate the presence of the upper full-length macroH2A1/2--Myc and a smaller macroH2A1/2--Myc-derived form. The relative concentration of nucleosomes/histones in each fraction is shown in the Coomassie image below.](0112074f2){#fig2}

Both macroH2A1 and macroH2A2 concentrate in distinct bands on the human and mouse Xi
------------------------------------------------------------------------------------

Previous observations have indicated that macroH2A1 is uniformly associated with the mouse Xi at metaphase ([@bib15]; [@bib41]). We have investigated the relationship of macroH2A with the human and mouse Xi and consistently observed a distinct banding pattern on the Xi chromosome ([Fig. 3](#fig3){ref-type="fig"}). As previously observed, macroH2A associates with the autosomes and active X chromosome (Xa) in human metaphase spreads as well, but at a significantly lower level than that for the Xi ([Fig. 3](#fig3){ref-type="fig"} c and [Fig. 4](#fig4){ref-type="fig"} a). The same banding pattern is observed using antisera specific to either macroH2A1 or macroH2A2, indicating that the bands contain both isoforms ([Fig. 3](#fig3){ref-type="fig"} a).

![**MacroH2A displays distinct banding patterns on the metaphase Xi chromosome.** (a) 46,XX (hTERT-RPE1) metaphase Xi chromosome stained with macroH2A1- or macroH2A2- (aa 124--180) specific pAb by indirect immunofluorescence (green, FITC), merged with DAPI staining (blue). The ideogram represents the metaphase Xi chromosome indicating the position of the X inactivation center (XIC) and the positions of the four main bands at Xp22, Xp11, Xq13, and Xq22-24. (b) Indirect immunofluorescence of macroH2A1 banding pattern on the Xi chromosome in 46,XX (hTERT-RPE1) cells merged with FISH signals (red, TRITC) for ordered X chromosome probes, and merged with DAPI image. The white arrowheads indicate the location of the specific FISH probes. Overlapping signals are in yellow. (c) Partial metaphase spread from a 46,XX (hTERT-HME1) cell line stained with macroH2A1 by indirect immunofluorescence, merged with X-α satellite FISH signals. The Xa and Xi are indicated. (d) Partial metaphase spread from a female mouse cell line (B144) stained with macroH2A1 by indirect immunofluorescence, merged with X chromosome--specific DXwas70 FISH signals. The Xa and Xi are indicated.](0112074f3){#fig3}

![**Overlap of the Xq22-24 macroH2A1 band with a band of histone H3 lysine-4 methylation centered at DXZ4.** (a) Female metaphase chromosomes from a macroH2A1-CT--Myc-transfected 46,XX (hTERT-RPE1) cell line counterstained with anti-DimH3K4. Chromosomes are stained with DAPI (blue; panel 1), and the distribution of macroH2A1 (green, FITC; panel 2) and DimH3K4 (red, TRITC; panel 3) are shown. The merged distribution of macroH2A1 and DimH3K4 are shown in panel 4 with overlapping signals in orange. White arrow points to the position of the Xi. (a′) Enlarged image of the Xi indicated, showing the macroH2A1 and DimH3K4 banding patterns on the Xi. The DAPI image is merged with the DimH3K4 signal in the top panel to indicate the relative position of the DimH3K4 signal on Xq. (b) 46,XX (hTERT-RPE1) Xi chromosomes showing the distribution of macroH2A1-CT--Myc, merged with the DAPI image. The distribution is indistinguishable from that seen for the endogenous macroH2A1 protein ([Fig. 2](#fig2){ref-type="fig"}). (c) 46,XX (hTERT-RPE1) Xi chromosomes showing the distribution of macroH2A1-NT--Xpr, merged with the DAPI image. (d) 46,XX (hTERT-RPE1) Xi chromosomes showing the distribution of DimH3K4 merged with either the DAPI image or the distribution of macroH2A1-CT--Myc, with overlapping signals shown in yellow. (e) 46,XX (hTERT-RPE1) Xi chromosomes showing the DXZ4 locus, merged with the DAPI image or the DimH3K4 signal. Overlapping DXZ4 and DimH3K4 signals are shown in yellow.](0112074f4){#fig4}

Up to four macroH2A bands were observed on the Xi in a variety of human 46,XX cell lines ([Fig. 3](#fig3){ref-type="fig"}; unpublished data). To determine the precise location of each band, we stained metaphase chromosomes with macroH2A in combination with FISH using a number of ordered and previously mapped X chromosome probes. This approach placed the macroH2A bands at Xp22, Xp11, Xq13, and Xq22-24, with the most intense and consistent band at Xq22-24 ([Fig. 3](#fig3){ref-type="fig"}). Notably, the band at Xq13 was indistinguishable from a cosmid probe containing the XIST locus at the X inactivation center ([Fig. 3](#fig3){ref-type="fig"} b). All four bands were reproduced in a 46,XX cell line overexpressing either an amino- or carboxy-terminal epitope-tagged form of macroH2A1 ([Fig. 4, b and c](#fig4){ref-type="fig"}), confirming the identity of the bands.

To extend this observation, we investigated the distribution of macroH2A1 on the mouse Xi at metaphase. As seen in humans, macroH2A1 formed a characteristic banding pattern on the mouse Xi ([Fig. 3](#fig3){ref-type="fig"} d). Intriguingly, the location of the bands within the distal portion of the mouse Xi correlates with sequences that are syntenic with human Xp22, Xp11, Xq13, and Xq22-24 ([@bib19]), suggesting a conserved role for macroH2A in these regions.

The macroH2A band at Xq22-24 overlaps with the site of histone H3 lysine-4 methylation
--------------------------------------------------------------------------------------

In addition to a reproducible banding pattern of macroH2A on the Xi, a distinct banding pattern of histone H3 lysine-4 methylation (DimH3K4) has been observed ([@bib7]). Human female metaphase chromosomes stained for macroH2A and DimH3K4 show a clear overlap of the distal boundary of the Xq22-24 macroH2A band with DimH3K4 ([Fig. 4](#fig4){ref-type="fig"}, a, a′, and d). The pattern of macroH2A and DimH3K4 at Xq22-24 is indistinguishable from that seen between macroH2A and FISH with a probe of the macrosatellite sequence DXZ4 ([Fig. 3](#fig3){ref-type="fig"} b, middle). FISH analysis confirms that the DimH3K4 band is centered at DXZ4 on Xq24 ([Fig. 4](#fig4){ref-type="fig"} e).

Centrosomal association of macroH2A1 alters during the cell cycle
-----------------------------------------------------------------

To address a possible temporal relationship between the chromosomal and centrosomal pools of macroH2A, we examined the localization of macroH2A1 throughout the cell cycle. Female cells were synchronized chemically at either the G~1~--S boundary and released into S phase toward mitosis, or blocked in mitosis and released into G~1~ toward S phase. The appearance of an MCB was most obvious during S phase, with the loss of the MCB as cells approached mitosis ([Fig. 5](#fig5){ref-type="fig"} a; [Table I](#tbl1){ref-type="table"}). In contrast, the proportion of cells demonstrating centrosomal localization of macroH2A1 increased as cells approached mitosis ([Fig. 5](#fig5){ref-type="fig"} a; [Table I](#tbl1){ref-type="table"}). MCB formation after release from mitosis required ∼12 h ([Fig. 5](#fig5){ref-type="fig"} a; [Table I](#tbl1){ref-type="table"}), whereas macroH2A1 was observed at the centrosome shortly after release. The same relationship of increased centrosome association and decreased MCB frequency as cells approach mitosis was observed in two other 46,XX cell lines (unpublished data), indicating that this is a common feature of human somatic cells.

![**Distribution of macroH2A1 in relation to the centrosome and XIST RNA through the somatic cell cycle.** (a) Distribution of macroH2A1 (green, FITC) and γ-tubulin (red, TRITC) in 46,XX (hTERT-RPE1) cells at different stages of the cell cycle as detected by indirect immunofluorescence. The nucleus is stained by DAPI (blue). Overlapping signals are shown in yellow. The positions of the centrosome (white arrowhead) and MCB (white arrow) are indicated. The stage of the cell cycle from which cells were released, G~1~--S or mitosis (M), are indicated along with the number of hours (h) after release. (b) Distribution of macroH2A1 and XIST RNA in 46,XX (hTERT-RPE1) cells at different stages of the cell cycle as detected by indirect immunofluorescence and RNA-FISH. The nucleus is stained by DAPI. Overlapping signals are shown in yellow. The position of the centrosome (white arrowhead) and MCB (white arrow) are indicated. The stage of the cell cycle from which cells were released, G~1~--S or mitosis (M), are indicated along with the number of hours (h) after release.](0112074f5){#fig5}

###### 

**Association of macroH2A1 with MCBs and** γ**-tubulin in 46,XX (hTERT-RPE1) cells at different stages of the cell cycle**

  Cell cycle stage       Cells with MCB   Cells with centrosome association   Cells with no MCB or centrosome association
  ---------------------- ---------------- ----------------------------------- ---------------------------------------------
  Early S phase          95 ± 1.4         54 ± 2.8                            2 ± \<0.01
  Mid to late S phase    74 ± 2.8         84 ± 2.8                            2 ± \<0.01
  Late S phase           52 ± 2.8         93 ± 1.4                            3 ± 1.4
  G~2~                   22 ± 2.8         93 ± 1.4                            4 ± 2.8
  Mitosis                0 ± \<0.01       5 ± 4.2                             95 ± 4.2
  Early G~1~             1 ± 1.4          55 ± 4.2                            45 ± 4.2
  Mid G~1~               3 ± 1.4          100 ± \<0.01                        0 ± \<0.01
  Late G~1~ to early S   39 ± 4.2         98 ± 2.8                            1 ± 1.4

Cells were synchronized at the G~1~--S boundary or in mitosis and released for 0--12 h before detection of macroH2A1 and γ-tubulin by indirect immunofluorescence. Numbers of cells are given as a percentage with standard deviations (*n* = 100). Early S phase, cells at the G~1~--S boundary; mid to late S phase, G~1~--S + 4 h; late S phase, G~1~--S + 8 h; G~2~, G~1~--S + 12 h; mitosis, release from nocodazole for 1 h; early G~1~, mitosis + 4 h; mid G~1~, mitosis + 8 h; late G~1~ to early S, mitosis + 12 h.

Although changes in the relative level of centrosomal macroH2A1 were observed as cells passed through S phase toward mitosis, the nucleosomal concentration of macroH2A1 did not appear to change significantly (unpublished data).

Formation of an MCB follows, but does not mirror, XIST RNA accumulation
-----------------------------------------------------------------------

Disruption of XIST RNA results in the loss of MCB formation ([@bib18]; [@bib3]), indicating dependence of macroH2A1 on XIST for Xi localization. To examine their temporal relationship in normal cells, we monitored MCB formation in relation to XIST RNA during the somatic cell cycle. XIST RNA paints the Xi during interphase ([@bib14]), but unlike mouse Xist ([@bib20]), human XIST RNA does not remain associated with the Xi during mitosis ([@bib14]). An XIST RNA domain was observed in cells throughout S phase and G~2~ and only dissociated from the Xi as cells entered mitosis ([Fig. 5](#fig5){ref-type="fig"} b; [Table II](#tbl2){ref-type="table"}), consistent with earlier findings ([@bib14]). XIST RNA was expressed and formed an XIST RNA domain shortly after release from mitosis ([Fig. 5](#fig5){ref-type="fig"} b; [Table II](#tbl2){ref-type="table"}). In contrast, MCBs dissociated from the Xi chromatin as cells approached mitosis, significantly earlier than XIST RNA, and did not rapidly reform with the XIST RNA territory shortly after mitosis ([Fig. 5](#fig5){ref-type="fig"} b; [Table II](#tbl2){ref-type="table"}). With the exception of a very small number of cells, an MCB was present only in cells with an XIST RNA domain. This indicates that although the association of XIST RNA with the Xi is a prerequisite for an MCB, the formation of an MCB is strongly influenced by the cell cycle.

###### Frequency of macroH2A1 MCBs and XIST RNA association with the Xi in 46,XX (hTERT-RPE1) cells at different stages of the cell cycle

  Cell cycle stage       Cells with MCB association with Xi   Cells XIST RNA association with Xi   Cells with no MCB XIST RNA association with Xi
  ---------------------- ------------------------------------ ------------------------------------ ------------------------------------------------
  Early S phase          81 ± 9.9                             99 ± 1.4                             1 ± 1.4
  Mid to late S phase    64 ± 5.6                             98 ± \<0.01                          1 ± 1.4
  Late S phase           48 ± 2.8                             99 ± 1.4                             0 ± \<0.01
  G~2~                   19 ± 4.2                             67 ± 4.2                             33 ± 4.2
  Mitosis                0 ± \<0.01                           1 ± 1.4                              99 ± 1.4
  Early G~1~             0 ± \<0.01                           68 ± 2.8                             32 ± 2.8
  Mid G~1~               5 ± 1.4                              99 ± 1.4                             1 ± 1.4
  Late G~1~ to early S   33 ± 4.2                             98 ± \<0.01                          1 ± 1.4

Cells were synchronized at the G~1~--S boundary or in mitosis and released for 0--12 h before detection of macroH2A1 and XIST RNA by indirect immunofluorescence and RNA FISH. Numbers of cells are given as a percentage with standard deviations (*n* = 100). Early S phase, cells at the G~1~--S boundary; mid to late S phase, G~1~--S + 4 h; late S phase, G1--S + 8 h; G~2~, G~1~--S + 12 h; mitosis, release from nocodazole for 1 h; early G~1~, mitosis + 4 h; mid G~1~, mitosis + 8 h; late G~1~ to early S, mitosis + 12 h.

MCB formation is influenced by the cell cycle and is most prominent during S phase
----------------------------------------------------------------------------------

To relate MCB formation directly with DNA replication during S phase, cells were synchronized and pulsed with BrdU for 1 h after different release times to detect exit and entry into S phase. Unlabeled cells after release from mitosis had not yet entered S phase ([Fig. 6](#fig6){ref-type="fig"} a), whereas unlabeled cells after release from G~1~--S had exited S phase and entered G~2~. Chromatin of the Xi is late replicating in S phase ([@bib26]; [@bib44]), and therefore the MCB is only labeled in late S phase cells ([Fig. 6](#fig6){ref-type="fig"} a). This, in combination with time of release, allows accurate determination of early, middle, and late S phase. Cells released from mitosis into G~1~ took ∼15 h to enter S phase as detected by BrdU incorporation. Only 23% of cells in G~1~ had an MCB ([Fig. 6](#fig6){ref-type="fig"} b). In contrast, MCBs were observed in 72% of cells in early S phase. MCB frequency peaked at 93% in cells 5 h after release from G~1~--S, before dropping sharply late in S phase and in G~2~. As shown in [Fig. 6](#fig6){ref-type="fig"} b, these data clearly indicate that the appearance of an MCB is most prominent during S phase, in agreement with timing of MCB formation after mitosis and loss of MCBs as cells pass through S phase ([Fig. 5](#fig5){ref-type="fig"}; [Tables I](#tbl1){ref-type="table"} and [II](#tbl2){ref-type="table"}).

![**Distribution of macroH2A1 in synchronized 46,XX (hTERT-RPE1) cells in different stages of the somatic cell cycle.** (a) The late G~1~ cell was released from mitosis for 14 h and pulsed with BrdU for 1 h before detection of macroH2A1 (green, FITC) and BrdU (red, TRITC). The nucleus is stained with DAPI (Blue). The cell has not yet entered S phase, as determined by the lack of an anti-BrdU signal. The early S phase cell was released from mitosis for 16 h and pulsed with BrdU for 1 h before detection of macroH2A and BrdU. The nucleus is stained with DAPI and merged with the anti-BrdU signal. The position of the MCB is indicated by the white arrowhead and, as indicated by the merged macroH2A1 and BrdU signals (yellow), has not yet undergone DNA replication. The late S phase cell was released from G~1~--S for 9 h and pulsed with BrdU for 1 h before detection of macroH2A1 and BrdU. The nucleus is stained with DAPI and merged with the anti-BrdU signal. The position of the MCB is indicated by the white arrowhead and, as indicated by the merged macroH2A1 and BrdU signals (yellow), is currently undergoing DNA replication. (b) Graph showing the frequency of MCB observation at different stages of the somatic cell cycle. Synchronized 46,XX cells (hTERT-RPE1) released for different time periods from the G~1~--S boundary or mitosis and pulsed for 1 h with BrdU. Cells were scored for the presence of an MCB at different cell cycle stages.](0112074f6){#fig6}

Inhibition of the 20S proteasome results in the accumulation of macroH2A1 at the centrosome
-------------------------------------------------------------------------------------------

The proteasome is a large multisubunit proteolytic complex that is the major site of protein degradation ([@bib5]). Components of the proteasome have been identified in purified centrosome fractions ([@bib55]) that are capable of degrading ubiquitinated substrates ([@bib21]). To evaluate the potential association of macroH2A1 with the proteasome, cells were synchronized at the G~1~--S boundary and in mitosis before releasing in the presence of lactacystin, an irreversible proteasome inhibitor ([@bib22]). Centrosomal accumulation of macroH2A1 significantly increased after incubation for 12 h in lactacystin and colocalized with an enlarged ubiquitin domain ([Fig. 7](#fig7){ref-type="fig"}), whereas an accumulation of macroH2A2 was not detected (unpublished data). The dramatic accumulation of macroH2A1 at the centrosome after inhibition of the proteasome is consistent with the inability to degrade the protein, suggesting that macroH2A1 may be targeted to the centrosome for degradation. The appearance of an enlarged macroH2A1 domain at the centrosome occurs between 8--12 h after release from G~1~--S or mitosis. More cells acquired an enlarged centrosomal macroH2A1 domain when released from G~1~--S (91% of cells) than from mitosis (71%), perhaps indicating that more macroH2A1 is targeted for degradation as cells pass through S phase and G~2~ than in G~1~. This may reflect the remodeling of chromatin in preparation for mitosis and the need to remove macroH2A1 released in this process.

![**Colocalization of macroH2A1 with ubiquitin and accumulation at the centrosomal proteasome over time with inhibition of the 20S proteasome.** 46,XX (hTERT-RPE1) cells were synchronized at G~1~--S or mitosis (M) and directly processed (0 h/1 h) or released for 12 h (12 h) in the presence of 10 μM lactacystin. The distribution of macroH2A1 (green, FITC) (mH2A) and ubiquitin (red, TRITC) (Ub) are shown by indirect immunofluorescence. The nucleus is stained with DAPI (blue). The white arrowheads indicate the position of the centrosome proteasome marked by ubiquitin, and the small white arrows indicate the position of MCBs. Overlapping macroH2A1 and ubiquitin (yellow) show colocalization and accumulation 12 h after G~1~--S and mitosis in the presence of the proteasome inhibitor lactacystin.](0112074f7){#fig7}

Centrosome association and accumulation is a feature of some, but not all, chromatin proteins
---------------------------------------------------------------------------------------------

To determine how specific macroH2A1 association with the centrosome is, we looked at a number of other chromatin proteins for centrosome association ([Fig. 8](#fig8){ref-type="fig"} a). Of 29 chromatin proteins tested, 8 demonstrated a clear overlap with γ-tubulin at mitosis ([Fig. 8](#fig8){ref-type="fig"} a) and interphase (unpublished data). To address the possibility that, like macroH2A1, the centrosomal association of these chromatin proteins represents a degradation pathway, cells were treated with lactacystin and monitored for the accumulation of each chromatin protein at the centrosome ([Fig. 8](#fig8){ref-type="fig"} b). Indeed, several of the chromatin proteins demonstrated a dramatic increase in size at the centrosome and colocalization with ubiquitin ([Fig. 8](#fig8){ref-type="fig"} b). In contrast, DNA--methyltransferase 3a (DNMT3a) remained absent from the centrosome, but consistently accumulated at two nuclear foci ([Fig. 8](#fig8){ref-type="fig"} b), suggesting that this protein is directed to an alternative proteasome center. Taken together, these data imply that targeting of chromatin proteins to the centrosome is a common mechanism of protein degradation.

![**Colocalization of a number of heterochromatin proteins with centrosomes at mitosis, and accumulation at the centrosome proteasome in the presence of lactacystin.** (a) Indirect immunofluorescence of heterochromatin proteins (green, FITC) with γ-tubulin (red, TRITC) in 46,XX (hTERT-RPE1) at mitosis. Chromosomes are stained with DAPI (blue). Overlapping heterochromatin protein signals and γ-tubulin signals in merged images are indicated in yellow. The different heterochromatin proteins are indicated to the left of each group of panels. (b) Extensive incubation of 46,XX (hTERT-RPE1) cells with lactacystin results in the accumulation of some, but not all, heterochromatin proteins at the centrosome proteasome. Cells were treated with 10 μM lactacystin for 14 h before processing. Ubiquitin and proteins indicated were detected by indirect immunofluorescence. Clear overlapping signals with ubiquitin can be seen (yellow). White arrowheads indicate the accumulation of Dnmt3a with two nuclear territories and not with the centrosome proteasome. Gene names are defined in the Materials and methods.](0112074f8){#fig8}

Discussion
==========

MacroH2A1 associates with the centrosome in a manner characteristic of a degradation pathway
--------------------------------------------------------------------------------------------

The association of macroH2A at the centrosome is not restricted to undifferentiated mouse ES cells ([@bib50]), but is a common feature of male and female mouse ([@bib42]) and human somatic cells ([Fig. 1](#fig1){ref-type="fig"} a). Centrosomal macroH2A is composed of both macroH2A1 and macroH2A2 ([Fig. 1](#fig1){ref-type="fig"} b and [Fig. 2](#fig2){ref-type="fig"} a), indicating that both proteins are spatially indistinguishable at the centrosome.

Recently, a link has been made between protein degradation pathways and the centrosome. Treatment of cells with lactacystin, a potent inhibitor of the 20S proteasome ([@bib22]), results in the dramatic formation of perinuclear protein aggregates ([@bib58]). In the absence of lactacystin, a variety of mutant misfolded or overexpressed proteins also accumulate in perinuclear aggregates (referred to as aggresomes) that are centered at the centrosome ([@bib33]; [@bib23]). Once aggresomes form, they appear to be highly resistant to proteolysis ([@bib38]) and are thought to be a major contributor to the pathology of disease ([@bib37]). Most compelling is the detection and purification of active components of the proteasome at the centrosome ([@bib55]; [@bib21]). The accumulation of macroH2A1 at the centrosome in the presence of lactacystin ([Fig. 7](#fig7){ref-type="fig"}) suggests that macroH2A1 is targeted to the centrosome--proteasome as part of a degradation pathway. In contrast, despite the association of macroH2A2 with the centrosome ([Fig. 1](#fig1){ref-type="fig"} b and [Fig. 2](#fig2){ref-type="fig"} a), an accumulation was not detected in the presence of lactacystin (unpublished data). One explanation for this could be that macroH2A2 is targeted primarily to a nuclear proteasome center for degradation with centrosomal proteasome--mediated degradation being secondary. Alternatively, lactacystin may prevent the export of macroH2A2 but not macroH2A1 from the nucleus. Ultimately, this may reflect a difference in the biology of the two macroH2A proteins, or a sensitivity issue regarding the antisera. Notably, poly-ADP ribose polymerase, an activator of the 20S proteasome to degrade histones damaged by oxidation in the nucleus ([@bib54]), is also located at the centrosome ([@bib34]) and may activate the centrosomal proteasome in a similar fashion.

Although a common feature of proteins targeted for degradation is the addition of polyubiquitin chains ([@bib49]), exhaustive immunoprecipitation experiments using antisera raised to ubiquitin failed to immunoprecipitate polyubiquitinated forms of macroH2A (unpublished data). Close examination of the extensive overlap in the macroH2A1 and ubiquitin signals in the aggresome indicates a hole in the macroH2A1 signal at the center of the aggresome ([Fig. 7](#fig7){ref-type="fig"}). This is also true of the macroH2A1 signal before lactacystin treatment ([Fig. 7](#fig7){ref-type="fig"}), placing macroH2A1 in the pericentriolar material, as confirmed by the absence of macroH2A1 signal at the centrioles marked by γ-tubulin ([Figs. 1](#fig1){ref-type="fig"} and [5](#fig5){ref-type="fig"}). Although ubiquitination is a common signal for targeting proteins to the proteasome ([@bib5]), other proteins are targeted to the proteasome for degradation in the absence of detectable ubiquitination ([@bib23]). Therefore macroH2A1 may be targeted to the proteasome in a ubiquitin-independent fashion or else macroH2A1 is targeted through a physical association with other ubiquitinated proteins. Alternatively, the mono-ubiquitinated form of macroH2A, which is readily detectable (unpublished data), may be sufficient for targeting for degradation as previously demonstrated for histone H3 ([@bib28]).

In addition to macroH2A1, a number of other chromatin proteins associate with the centrosome ([@bib30]; [@bib2]; [@bib59]) ([Fig. 8](#fig8){ref-type="fig"} a). Like macroH2A1, treatment of cells with lactacystin results in the association of some, but not all, chromatin proteins with aggresomes ([Fig. 8](#fig8){ref-type="fig"} b). This indicates that targeting of chromatin proteins to the centrosomal proteasome is a fairly common mechanism. The fact that DNMT3a not associated with the centrosome ([Fig. 8](#fig8){ref-type="fig"} a) is consistently targeted to two nuclear proteolysis centers ([Fig. 8](#fig8){ref-type="fig"} b), and not to the centrosomal proteasome, indicates that different chromatin proteins are targeted to different proteolysis centers. In addition, export from the nucleus is not a requisite for chromatin protein degradation, and the site of degradation for each protein is specific. Why a selection of nuclear proteins is targeted to the centrosomal proteasome, instead of the proteolysis centers in the nucleus, is unclear. Given its association with gene silencing ([@bib46]), it is possible that nonnucleosomal macroH2A1 may retain the ability to interact with partners in the nucleus and thus needs to be rapidly exported to prevent macroH2A1 from having detrimental effects on the cell by sequestering chromatin complexes. Alternatively, factors involved in the remodeling of chromatin, resulting in the potential release of macroH2A1, may themselves be targeted to the centrosomal proteasome, taking macroH2A1 with them.

Centrosomal concentrations of macroH2A1 alter in a cell cycle--dependent fashion. As cells proceed through S phase and G~2~ toward mitosis, the concentration of macroH2A1 at the centrosome increases to a level detectable by immunofluorescence ([Fig. 5](#fig5){ref-type="fig"} a; [Table I](#tbl1){ref-type="table"}). The same trend is observed as cells proceed from mitosis through G~1~ toward S phase ([Fig. 5](#fig5){ref-type="fig"} a; [Table I](#tbl1){ref-type="table"}). The accumulation of macroH2A1 at the centrosome in the presence of lactacystin is most prominent in cells as they pass through S phase toward mitosis. This is consistent with the need to target more macroH2A1 for degradation, as it is during this period that the MCB disappears, suggesting that excess quantities of macroH2A1 are required to be removed.

The association of macroH2A1 with the Xi chromatin is most prominent at S phase
-------------------------------------------------------------------------------

A prerequisite for the formation of an MCB is the association of XIST RNA with the Xi ([@bib18]; [@bib3]). Whereas XIST RNA coats the Xi through early G~1~ to late G~2~, the stable presence of XIST does not immediately direct macroH2A1 to the Xi to form an MCB ([Fig. 5](#fig5){ref-type="fig"} b; [Table II](#tbl2){ref-type="table"}). Instead, the formation of an MCB is most common in early and middle S phase ([Fig. 6](#fig6){ref-type="fig"} b). MacroH2A1 is unlikely to be marking chromatin for late replication, as not all sites of late replication overlap with macroH2A1 staining ([Fig. 6](#fig6){ref-type="fig"} a), and the banding of macroH2A at metaphase ([Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) does not correspond to regions of the Xi known to replicate latest in S phase ([@bib56]).

The cell cycle--influenced appearance of an MCB suggests that macroH2A1 (and perhaps macroH2A2) may be substituting the H2A position in Xi nucleosomes at and around S phase. Although the nucleosome inner core of histones H3 and H4 is stable at interphase, H2B is more dynamic and can readily be substituted ([@bib36]). H2A and H2B are deposited onto chromatin as a heterodimer ([@bib51]). Therefore it is conceivable that H2A variants, like H2B, can also dynamically exchange the H2A position, conferring alternative states to local chromatin. Preparations of nucleosomes from cells blocked at the beginning of S phase or in mitosis have comparable levels of macroH2A1 (unpublished data), despite the significant decrease in macroH2A at the Xi as the MCB disappears ([Fig. 5](#fig5){ref-type="fig"}). Put into a genomic perspective, fluctuations in the local concentrations of macroH2A1 at the Xi visualized as an MCB in females may be masked by the total concentrations of nucleosomal macroH2A1 in a cell. This may indicate that macroH2A1 at the MCB represents only a small fraction of the total concentration of macroH2A1, with the remainder functioning in autosomal chromatin ([Fig. 3](#fig3){ref-type="fig"} c and [Fig. 4](#fig4){ref-type="fig"} a). Indistinguishable concentrations of macroH2A in male and female nucleosome fractions and total cell extracts support this (unpublished data). More speculatively, it is conceivable that macroH2A1 at the MCB is not all nucleosomal, but functioning with other components of the dosage compensation complex at the Xi outside of the nucleosome context. Resolving this issue will require a detailed analysis of nucleosome levels of macroH2A at the Xi by chromatin immunoprecipitation analysis at different stages of the cell cycle.

One possible model to explain the functional significance of the MCB during S phase is that higher local concentrations of macroH2A may be one of many redundant mechanisms to promote the loading of the dosage compensation complex onto the daughter X and mark it as the Xi as it is synthesized.

MacroH2A is enriched at specific bands on the metaphase Xi overlapping a site of histone H3 methylation
-------------------------------------------------------------------------------------------------------

Although the MCB is not evident before the onset of mitosis ([Fig. 5](#fig5){ref-type="fig"}; [Tables I](#tbl1){ref-type="table"} and [II](#tbl2){ref-type="table"}), macroH2A1 does remain associated with both the human and mouse Xi during mitosis as distinct bands ([Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Intriguingly, these bands appear to mimic the banding seen with Xist RNA on the mouse Xi during mitosis ([@bib20]), suggesting that macroH2A may be functioning to anchor Xist RNA in cis with the Xi. However, in humans, XIST RNA does not remain associated with the Xi during mitosis ([@bib14]). Bands enriched for macroH2A may function as reentry sites for XIST RNA and the dosage compensation complex, assisting in the rapid spread along the Xi in a manner analogous to reentry sites of the *Drosophila* dosage compensation complex ([@bib40]). The band of macroH2A at the site of the *XIST* locus ([Fig. 3](#fig3){ref-type="fig"} b) is perhaps analogous to reentry of the *Drosophila* dosage compensation complex at the site of the *roX1* and *roX2* loci ([@bib35]). Why macroH2A remains associated specifically with these regions of the chromosome is intriguing. With the exception of the proximity of macroH2A to the satellite repeat DXZ4 at Xq22-24 ([@bib25]), there are no obvious shared features, such as gene densities or frequency of repeated elements at the chromatin of the other identified regions.

Most intriguing is the clear overlap of the macroH2A band at Xq22-24 with a band of histone H3 lysine-4 methylation ([Fig. 4](#fig4){ref-type="fig"}, a, a′, and d). The band of DimH3K4 is centered at DXZ4 ([Fig. 3](#fig3){ref-type="fig"} e) and marks the distal edge of the macroH2A band. This demonstrates the association of a histone modification, thought primarily to associate with euchromatin and regions of transcriptional activation ([@bib39], and references therein), with a macrosatellite repeat ([@bib25]). Potentially, DXZ4 may act as a boundary element, delimiting the spread of macroH2A, strengthened by the H3 lysine-4 methylation. Identification of genomic sequences and chromatin modifications at the boundary of each of the macroH2A bands will provide invaluable insight into the functional significance and influence of the histone code used by the Xi.

The MCB observed in interphase and the banding of macroH2A seen at metaphase ([Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) might provide similar or separate functions. Although disruption of XIST results in the loss of detectable MCB formation ([@bib18]; [@bib3]), this may not effect macroH2A at the chromosome bands. Targeting of macroH2A1 and macroH2A2 in human and mouse ES cells, along with carefully directed chromatin immunoprecipitation experiments, will further our understanding of the functional significance of macroH2A in X inactivation.

Materials and methods
=====================

Cell culture and chemical treatment
-----------------------------------

Cell lines used include T-3352, a 46,XX human primary fibroblast strain (provided by Stuart Schwartz, Case Western Reserve University); hTERT-RPE1, a 46,XX telomerase-immortalized cell line derived from a human retinal pigment epithelial cell line RPE-340 (catalog no. C4000--1; CLONTECH Laboratories, Inc.); hTERT-BJ1, a 46,XY telomerase-immortalized cell line derived from a human primary foreskin fibroblast cell line (catalog no. C4001--1; CLONTECH Laboratories, Inc.); hTERT-HME1, a 46,XX telomerase-immortalized cell line derived from a human mammary epithelial cell line (catalog no. C4002--1; CLONTECH Laboratories, Inc.); and HEK-293, a female fetal kidney tumor cell line. B144 is a female mouse primary fibroblast cell line (provided by Laura Carrel, Case Western Reserve University). Cells were maintained as described previously ([@bib12]).

To establish stably transfected cell lines, hTERT-RPE1 or HEK-293 cells were transfected with 5 μg of carboxy-terminal Myc-tagged macroH2A1 (macroH2A1-CT--Myc), amino-terminal Xpress-tagged macroH2A1 (macroH2A1-NT--Xpr), or a carboxy-terminal Myc-tagged macroH2A2 (macroH2A2-CT--Myc) expression using Superfect according to the manufacturer\'s recommendations (QIAGEN) and grown for 48 h before selection with either 1.4 mg/ml (hTERT-RPE1) or 0.4 mg/ml (HEK-293) neomycin (GIBCO BRL).

Cell synchronization and BrdU (Sigma-Aldrich) incorporation were performed as previously described ([@bib53]).

Inhibition of the 20S proteasome was achieved by washing cell lines twice with PBS and applying complete media containing 10 μM lactacystin (Calbiochem) ([@bib22]) for the time periods indicated at 37°C in a 5% CO~2~ atmosphere.

Antibodies
----------

Rabbit pAbs against the nonhistone tail region of macroH2A1 have been previously described ([@bib12]). Two glutathione-*S*-transferase (GST)--macroH2A2 fusion proteins covering amino acids 124--180 (aa 124--180) and amino acids 124--372 (aa 124--372) were used to raise independent rabbit pAbs to macroH2A2 (Covance Inc.). MacroH2A1 and macroH2A2 (124--180) pAbs were affinity purified. MacroH2A1 and both macroH2A2 antisera were blocked against each other using standard techniques ([@bib29]) to generate antisera specific to each form of the protein. Specificity was confirmed by Western analysis (unpublished data). Monoclonal anti--γ-tubulin (clone gtu-88) was obtained from Sigma-Aldrich. Mouse mAb anti-BrdU (clone BMC 9318) was obtained from Roche Diagnostics Corp. Mouse mAb antiubiquitin (clone 6C1) was obtained from Oncogene Research Products. Polyclonal antisera raised to histone deacetylases 1 (HDAC1, sc-7872) and 3 (HDAC3, sc-8138), DNA--methyltransferases 1 (Dnmt1, sc-10222), 2 (Dnmt2, sc-10227), 3a (Dnmt3a, sc-10231), and 3b (Dnmt3b, sc-10235), histone acetyltransferase p300/CBP-associated factor (PCAF, sc-8999), and methyl-DNA binding proteins 1 (MBD1, sc-9395) and 3 (MBD3, sc-9402) were obtained from Santa Cruz Biotechnology Inc. Antihistone H3 dimethyl lysine-4 (DimH3K4) was obtained from Upstate Biotechnology. Anti--Mi-2 was a gift from Paul Wade (Emory University, Atlanta, GA). Mouse mAbs anti-Myc and anti-Xpress were obtained from Invitrogen.

Immunofluorescence and FISH
---------------------------

Immunofluorescence and FISH was performed essentially as previously described ([@bib13]). Slides were denatured at 85°C before FISH, as opposed to 72°C, to overcome extensive sample fixation. A digoxygenin-labeled DXZ4 probe was obtained from Oncor Inc. Human X chromosome TRITC-labeled probes were generated using a nick translation kit (Vysis Inc). A mouse X chromosome--specific probe, DXwas70, was used to detect the mouse X chromosome. Human cosmid clones *ICRFc100H0130* (XIC) and *ICRFc100G11100* (CIC8) were obtained from the Imperial Cancer Research Fund Reference Library Database. Immuno-RNA FISH was achieved by first immunostaining followed by RNA-FISH essentially as previously described ([@bib14]).

Metaphase chromosomes were prepared as described previously ([@bib13]). Single-copy probes were blocked for repetitive sequences for 1 h at 37°C in the presence of 0.3 mg/ml human Cot-1 DNA before hybridization. Immunostaining of BrdU-pulsed cells was achieved by first fixing and staining for macroH2A as described previously ([@bib12]), before proceeding as described by [@bib53].

Images were collected with a Vysis imaging system equipped with a cooled CCD camera (Photometrics) controlled via the Quips M-FISH^TM^ software (Vysis Inc).

Relative cell cycle stages were determined by cell cycle arrest and release in conjunction with BrdU pulse labeling. Presence or absence of BrdU incorporation was monitored relative to the number of hours after release and translated directly to subsequent surveys.

Preparation of centrosomes and nucleosomes
------------------------------------------

Centrosomes were isolated essentially as previously described ([@bib8]). Nucleosome oligomers were isolated as described previously ([@bib13]). Protein samples were separated by SDS-PAGE and transferred to a polyvinylidene diflouride membrane using standard techniques ([@bib29]).

The authors would like to thank Dr. Stuart Schwartz, Dr. Laura Carrel, and Jim Amos-Landgraf (Case Western Reserve University) for cell lines and constructs and Dr. Paul Wade for the anti-Mi2 antisera. The authors thank Lisa Chadwick and Cory Valley for suggestions and constructive discussion.

This work was supported by research grant GM45441 to H.F. Willard from the National Institutes of Health. B.P. Chadwick is supported by a postdoctoral fellowship from the Rett Syndrome Research Foundation.

Abbreviations used in this paper: DNMT, DNA-methyltransferase; ES, embryonic stem cells; MCB, macrochromatic body; Xa, active X chromosome; Xi, inactive X chromosome; XIST, Xi-specific transcript.

[^1]: Address correspondence to H.F. Willard, Research Institute, Lakeside 1400, University Hospitals of Cleveland, 11100 Euclid Ave., Cleveland, OH 44106. Tel.: (216) 844-5936. Fax: (216) 844-5540. E-mail: <willard@uhri.org>
